Adage Capital Partners Gp, L.L.C. Centessa Pharmaceuticals PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 8,403,000 shares of CNTA stock, worth $193 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
8,403,000
Previous 6,954,000
20.84%
Holding current value
$193 Million
Previous $100 Million
10.42%
% of portfolio
0.2%
Previous 0.19%
Shares
9 transactions
Others Institutions Holding CNTA
# of Institutions
127Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$459 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$229 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$223 Million4.43% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$150 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.91MShares$136 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.17B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...